01 1Teva Pharmaceutical Industries
01 1IVOSIDENIB
01 1Israel
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-03-02
Pay. Date : 2021-12-14
DMF Number : 36151
Submission : 2022-02-04
Status : Active
Type : II
20
Teva Pharmaceutical Industries Ltd, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is IVOSIDENIB, with a corresponding US DMF Number 36151.
Remarkably, this DMF maintains an Active status since its submission on February 04, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 02, 2022, and payment made on December 14, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
